Zou Fei-Yan, Xie Hai-Long, Chen Zhu-Chu, He Chun-Mei, Guan Yong-Jun, Li You-Jun
Laboratory of Tumor Cell Biology, Cancer Research Institute, Xiangya School of Medicine, Central South University, Changsha, Hunan, PR China.
Ai Zheng. 2003 Nov;22(11):1121-6.
BACKGROUND & OBJECTIVE: HLCDG1, which locates in chromosome 5q33 (between D5S436 and D5S470),is a novel gene that our laboratory has cloned recently. The expression of HLCDG1 gene was significantly down-regulated or deleted in the primary lung carcinoma. This study was designed to observe if HLCDG1 has the potential to suppress growth of lung carcinoma cells.
The recombinant plasmid, pcDNA3.1(+)/HLCDG1, was constructed and subsequently transfected into A549 cells through liposome transfection. The A549 cells stably expressing HLCDG1 gene were established by G418 selection. RT-PCR was used to demonstrate the expression of HLCDG1 gene. Furthermore, the cell proliferation assay, the soft agar assay, and the tumorigenesis assay were used to analyze the malignant phenotype of the HLCDG1-transfected cells.
The HLCDG1-transfected cells exhibited the expression of HLCDG1 mRNA by RT-PCR. The population double time (PDT) of HLCDG1-transfected group, vector-transfected group, and nontransfected group were 70.0 hours, 43.3 hours, and 39.5 hours, respectively; the difference between HLCDG1-transfected group and the other two groups was significant (P< 0.05). The colony formation rates of HLCDG1-transfected group, the vector-transfected group, and nontransfected group were 8.5%, 29.0%, and 35.0%, respectively. The rate of HLCDG1-transfected cells was markedly lower than those of the other two groups (P< 0.05). Moreover, these clones were injected into athymic nude mice. After 43 days, they were killed, and their tumors were isolated. These tumors weighed 0.120g, 0.612g, and 0.924g, respectively.
The expression of HLCDG1 in A549 cells may have the potential to suppress tumor cell growth and the tumorigenesis of A549 cells transplanted in nude mice. These results suggested that HLCDG1 gene might be a good candidate of tumor suppressor gene correlated with lung carcinoma.
HLCDG1基因定位于5号染色体q33区域(在D5S436和D5S470之间),是本实验室最近克隆的一个新基因。在原发性肺癌中,HLCDG1基因的表达显著下调或缺失。本研究旨在观察HLCDG1是否具有抑制肺癌细胞生长的潜能。
构建重组质粒pcDNA3.1(+)/HLCDG1,随后通过脂质体转染将其导入A549细胞。经G418筛选建立稳定表达HLCDG1基因的A549细胞株。采用RT-PCR检测HLCDG1基因的表达。此外,通过细胞增殖实验、软琼脂实验及致瘤实验分析转染HLCDG1基因细胞的恶性表型。
经RT-PCR检测,转染HLCDG1基因的细胞呈现HLCDG1 mRNA表达。HLCDG1转染组、载体转染组和未转染组的群体倍增时间(PDT)分别为70.0小时、43.3小时和39.5小时;HLCDG1转染组与其他两组之间差异有统计学意义(P<0.05)。HLCDG1转染组、载体转染组和未转染组的集落形成率分别为8.5%、29.0%和35.0%。HLCDG1转染细胞的集落形成率明显低于其他两组(P<0.05)。此外,将这些克隆细胞接种于裸鼠体内。43天后处死裸鼠,分离肿瘤。这些肿瘤的重量分别为0.120g、0.612g和0.924g。
HLCDG1在A549细胞中的表达可能具有抑制肿瘤细胞生长及裸鼠体内移植的A549细胞致瘤的潜能。这些结果提示HLCDG1基因可能是与肺癌相关的抑癌基因的良好候选基因。